MENU
JAZZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jazz Pharmaceuticals (JAZZ) Earnings Date & Reports

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology... Show more

A.I. Advisor
published Earnings

JAZZ is expected to report earnings to fall 28.41% to $5.82 per share on March 03

Jazz Pharmaceuticals JAZZ Stock Earnings Reports
Q4'25
Est.
$5.82
Q3'25
Beat
by $2.20
Q2'25
Missed
by $0.63
Q1'25
Missed
by $3.13
Q4'24
Beat
by $0.81
The last earnings report on November 05 showed earnings per share of $8.13, beating the estimate of $5.93. With 341.75K shares outstanding, the current market capitalization sits at 8.30B.
View a ticker or compare two or three
JAZZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JAZZ showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Waterloo Road
Phone
+353 16347800
Employees
2800
Web
https://www.jazzpharmaceuticals.com